StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.82+0.03 (+3.89%)

Close on Nov 17, 2026Market cap $94.88MP/E –Yield –

NovaBridge Biosciences EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

NovaBridge Biosciences's EV/EBITDA was 16.5× on Feb 28, 2022, against 45.6× a year earlier.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2022Feb 28, 202216.5×−17.5
2021Dec 31, 202133.9×–

More NovaBridge Biosciences figures

See a number that looks wrong?